PubMed Health⌕ Search

Biomedical subjects

F Fiaccadori

Publications and source records attributed to F Fiaccadori.

At least 73 records · Page 4Linked to original sources

Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy.

Plasma and cerebrospinal fluid amino acid levels wee measured in 12 cirrhotic patients in grade 0 hepatic encephalopathy and 17 in grade 3-4 hepatic encephalopathy. In 5 of these patients amino acid determinations were performed during the evolution of the encephalopathy. No correlation was found between the degree of hepatic encephalopathy and the plasma amino acid imbalance. In the CSF of cirrhotic patients without encephalopathy, a significant increase was found in nearly all amino acids, including those known to not easily cross the blood-brain barrier; this suggests the presence of a nonspecific modification of the blood-brain barrier permeability. In patients with severe hepatic encephalopathy, the further increase only in cerebrospinal fluid aromatic amino acids and methionine levels suggests the presence of a selective stimulation of the neutral amino acid transport system across the blood-brain barrier. Finally, the good correlation between glutamine and the sum of neutral amino acids found in the cerebrospinal fluid only in the presence of encephalopathy supports the hypothesis that brain glutamine may stimulate neutral amino acid transport across the blood-brain barrier.

Adult↗

[Significance of the carcinoembryonic antigen (CEA) in the diagnosis of hepatopathies].

The significance of carcinoembryogenic antigen (CEA) is assessed as a way to obtaining a better definition of neoplasia of the liver and bile ducts, and the spotting of possible malignant degeneration in chronic diseases of the liver. The literature data on involvement of the liver and bile ducts in CEA metabolism are cited, and the results of a study of 419 patients with acute and chronic diseases of varying aetiology and severity, and benign or malignant obstructive icterus are presented. CEA measurements, while associated with a tendency towards high values in liver diseases with major functional damage, do not seem to be differentiating for cirrhosis and Ca-cirrhosis, or between benign and malignant icterus. Dependable diagnosis, therefore, depends on the inclusion of CEA in a battery of tests to be coupled with appraisal of the individual clinical and instrumental findings.

Carcinoembryonic Antigen↗

[Non-A, non-B hepatitis. Seroimmunological, epidemiological and clinical findings].

The characteristics of a third type of viral hepatitis, defined as non-A, non-B are analysed on the basis of the most recent reported findings. The problems of identification of the aetiological agent, its transmisibility in animals, the carrier condition, its possible evolution into chronic and fulminating forms, the effectiveness of immune globulin prophylaxis and epidemiological and clinical aspects are discussed. Reference is then made to the results of an epidemiological study of 293 patients with acute viral hepatitis, admitted to the Infectious Diseases Division of Parma Hospital. Diagnosis of non-A, non-B hepatitis was formulated, by exclusion, in 64 cases (21.8%). Intragroup studies pointed to an intermediate period of incubation and clinico-biochemical picture between A and B hepatitis the possible non-parenteral contagion route and possibilities of recurrence and development into chronic forms. Further information on hepatitis or on non-A, non-B hepatitis, can be provided by screenings based on antigen C demonstration (AgHC).

Acute Disease↗

[Radioimmunologic determination of hepatitis antigen and its clinical implications].

The AA. carrie out an analysis of the results obtained by means of the radioimmunologic method and concludes as follows: 1) Au-positive acute hepatitis represent the more largely diffused form among adult people; 2) from a clinical point of view, it seems appropriate to modify definitions of A and B hepatitis, of infectious hepatitis or serum hepatitis, classifying this disease as follows: a) hepatitis with positive antigenemy; b) hepatitis with negative antigenemy; and this independently from the anamnestic and epidemiologic elements. In the second part of this report, the AA., after introducing some considerations on the effects of the therapy by means of steroids, illustrate the data concerning a study carried out on a group of Au-positive and Au-negative subjects, subdivided into treated and non treated patients. From these analysis, even if a statistical survey has not been made, no elements are noticed, able to differentiate the behaviour of the two groups of hepatitis studied, in comparison with the therapy by means of steroids. One single Au-negative case, within a certain period of time, after the therapy with steroids, showed the presence of a positivity of immunologic phenomena only by the radioimmunoassay.

Adolescent↗

Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid.

The aim of the study was to verify the role of gamma-aminobutyric acid in the pathogenesis of hepatic encephalopathy occurring in cirrhotic patients by attempting to correlate plasma and cerebrospinal fluid content of authentic gamma-aminobutyric acid with the neurological manifestations of hepatic encephalopathy. For this purpose, plasma and cerebrospinal fluid gamma-aminobutyric acid levels were measured by means of mass fragmentography in 17 cirrhotic patients with hepatic encephalopathy and in 6 cirrhotics without neurological symptoms. Moreover, in all patients, a second sample was obtained during the clinical course of hepatic encephalopathy. The mean plasma and cerebrospinal fluid gamma-aminobutyric acid levels were not different in patients with or without hepatic encephalopathy and did not change during the evolution of the neurological symptoms. The lack of changes in the gamma-aminobutyric acid content in plasma and cerebrospinal fluid during hepatic encephalopathy is in contrast with the hypothesized importance of increased entry into the brain of gamma-aminobutyric acid in the pathogenesis of hepatic encephalopathy.

Adult↗

The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.

The HBeAg/anti-HBe system was studied as a marker of infectivity and chronic progressive liver disease in 460 hemodialysis patients. The importance of HBeAg as an index of infectivity was confirmed in that it was present simultaneously with specific DNA polymerase (31 patients) and by the presence of widely diffuse core particles in the hepatocyte nuclei (revealed by biopsy in six patients). In contrast, HBeAg showed no useful correlation with progressive liver disease, the absence of which was confirmed in all cases by biochemical and histological studies.

Biopsy↗

Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.

A total of 210 patients consecutively submitted to heart surgery at the Parma University Hospital and transfused with 1,898 units of blood were followed after transfusion in order to evaluate both the incidence of anti-hepatitis C virus (HCV) seroconversion in non-A, non-B post-transfusion hepatitis (PTH-NANB) cases and the usefulness of the screening for anti-HCV in comparison with that for serum glutamic pyruvic transaminase (SGPT) values in preventing PTH-NANB transmission. Fifteen recipients developed PTH-NANB (group A); ten of them (66.6%) showed anti-HCV seroconversion within 3-12 months. Eight of the ten anti-HCV positive patients developed chronic hepatitis, but none of the five PTH-NANB anti-HCV negative did. None of the 15 controls (group B) randomly chosen among the patient population showed anti-HCV seroconversion. A close correlation with the transmission of PTH was showed by anti-HCV positivity but not by SGPT elevation in blood donors. Eleven of 172 blood products transfused to group A but none of 139 products transfused to group B were anti-HCV positive. The incidence of elevated SGPT values was similar between the two groups of the transfused blood products. Nevertheless, the correlation observed between anti-HCV positivity and SGPT levels in the blood products involved in PTH confirms the need to exclude blood donors with abnormal SGPT values. On the whole, anti-HCV screening of donors showed a predictive value higher than that of SGPT (100% vs. 53.3%), allowing a minor blood donation exclusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Alanine Transaminase↗